Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,639 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.
Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N. Kasahara A, et al. Among authors: hayashi k, hayashi n. J Viral Hepat. 2004 Mar;11(2):148-56. doi: 10.1046/j.1365-2893.2003.00481.x. J Viral Hepat. 2004. PMID: 14996350
Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response.
Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N. Imai Y, et al. Among authors: hayashi k, hayashi n. J Gastroenterol. 2004 Nov;39(11):1069-77. doi: 10.1007/s00535-004-1448-0. J Gastroenterol. 2004. PMID: 15580400
[Interferon treatment for aged patients with hepatitis C].
Hiramatsu N, Kasahara A, Hayashi N, Imai Y. Hiramatsu N, et al. Among authors: hayashi n. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):640-4. Nihon Rinsho. 2004. PMID: 15359876 Review. Japanese. No abstract available.
Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group.
Kasahara A, Hayashi N, Mochizuki K, Hiramatsu N, Sasaki Y, Kakumu S, Kiyosawa K, Okita K. Kasahara A, et al. Among authors: hayashi n. J Viral Hepat. 2000 Sep;7(5):343-51. doi: 10.1046/j.1365-2893.2000.00250.x. J Viral Hepat. 2000. PMID: 10971822 Clinical Trial.
Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance.
Katayama K, Kasahara A, Sasaki Y, Kashiwagi T, Naito M, Masuzawa M, Katoh M, Yoshihara H, Kamada T, Mukuda T, Hijioka T, Hori M, Hayashi N. Katayama K, et al. Among authors: hayashi n. J Viral Hepat. 2001 May;8(3):180-5. doi: 10.1046/j.1365-2893.2001.00274.x. J Viral Hepat. 2001. PMID: 11380795 Clinical Trial.
Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin.
Oze T, Hiramatsu N, Yakushijin T, Kurokawa M, Igura T, Mochizuki K, Imanaka K, Yamada A, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Tamura S, Yoshihara H, Hayashi E, Inoue A, Imai Y, Kato M, Yoshida Y, Tatsumi T, Ohkawa K, Kiso S, Kanto T, Kasahara A, Takehara T, Hayashi N. Oze T, et al. Among authors: hayashi e, hayashi n. J Viral Hepat. 2009 Aug;16(8):578-85. doi: 10.1111/j.1365-2893.2009.01116.x. Epub 2009 Jun 22. J Viral Hepat. 2009. PMID: 19552663
3,639 results